The von Hippel-Lindau disease (VHL) gene is a putative tumor suppresso
r gene responsible for VHL, an autosomal dominantly inherited multitum
or syndrome. It is also implicated in the development of sporadic tumo
rs including clear cell renal carcinoma and central nervous system hem
angioblastoma. To define the molecular basis of VHL patients in Japane
se populations, we tested for germline mutations of the VHL gene in 45
unrelated Japanese VHL patients by single-strand conformation polymor
phism (SSCP) analysis and Southern blot analysis. We detected 23 (51%)
intragenic mutations and three (6.7%) deletions by SSCP analysis and
Southern blot respectively. The intragenic mutations consisted of 14 m
issense mutations, sever! microdeletions or insertions and two splice-
site mutations. Interestingly, nine of 10 mutations in exon 1 are loca
lized in a short region of 37 nucleotides. Five unique sites of mutati
on were included, which were not seen in previous studies. Unlike West
ern VHL patients, nonsense mutations were not found in Japanese VHL pa
tients. If the presence of pheochromocytomas is regarded as a phenotyp
ic marker for VHL classification, the mutations found in 22 VHL patien
ts without pheochromocytoma consisted of 11 missense mutations, six mi
crodeletions or insertions, two splice-site alterations and three dele
tions. The mutations found in four VHL patients with pheochromocytomas
consisted of one missense mutation at nucleotide 683 (codon 228), two
missense mutations at nucleotide 712 (codon 238) and a novel 20 bp in
sertion at nucleotide 776 (codon 259). Although the mutations in codon
238 are the mutational hot spot found in Western VHL patients with ph
eochromocytomas, a 20 bp insertion of original VHL cDNA sequence, from
nucleotide 777 to 796, is a unique mutation. Our results suggest that
mutations in Japanese VHL patients contain some unique features compa
red with those in Western patients. VHL gene has a critical role for t
he etiology in VHL in Japanese populations as well as Western VHL.